Evidence map›Paper›PMID 39418382›Full record

ArticleScience (New York, N.Y.)2024

Description and functional validation of human enteroendocrine cell sensors.

Joep Beumer, Maarten H Geurts, Veerle Geurts, Amanda Andersson-Rolf, Ninouk Akkerman, Franziska Völlmy, Daniel Krueger, Georg A Busslinger, Adriana Martínez-Silgado, Charelle Boot and 10 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Regional organization of nutrient absorption across the small intestine.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Population imaging of enterochromaffin cell activity reveals regulation by somatostatin.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Joep Beumer *Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0000-0002-2055-4444
Maarten H Geurts *Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0009-0006-8832-3745
Veerle Geurts *Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0009-0000-4758-1883
Amanda Andersson-Rolf *Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.
Ninouk AkkermanInstitute of Human Biology, Roche Pharma Research and Early Development, Roche Innovation Center Basel, CH-4070 Basel, Switzerland.ORCID 0000-0003-0547-3993
Franziska VöllmyPharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, CH-4070 Basel, Switzerland.ORCID 0000-0002-0345-1910
Daniel KruegerHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0000-0003-1139-7755
Georg A BusslingerHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0000-0002-7851-9895
Adriana Martínez-SilgadoHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.
Charelle BootHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.
Fjodor A Yousef YengejHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.
Jens PuschhofHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0000-0001-9275-4034
Wiline J Van de WeteringThe Maastricht Multimodal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, Netherlands.ORCID 0000-0003-0311-978X
Kevin KnoopsThe Maastricht Multimodal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, Netherlands.ORCID 0000-0002-7539-1160
Carmen López-IglesiasThe Maastricht Multimodal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, Netherlands.
Peter J PetersThe Maastricht Multimodal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, Netherlands.ORCID 0000-0002-2964-5684
Judith A ViviéSingle Cell Discoveries BV, 3584 BW Utrecht, Netherlands.
Dylan MooijmanSingle Cell Discoveries BV, 3584 BW Utrecht, Netherlands.ORCID 0000-0002-7382-9579
Johan H van EsHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0000-0002-1338-7078
Hans CleversHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and Oncode Institute, UMC Utrecht, 3584 CT Utrecht, Netherlands.ORCID 0000-0002-3077-5582

Funding

European Research Council 101020405
6 · The paper itself

Abstract

Enteroendocrine cells (EECs) are gut epithelial cells that respond to intestinal contents by secreting hormones, including the incretins glucagon-like peptide 1 (GLP-1) and gastric inhibitory protein (GIP), which regulate multiple physiological processes. Hormone release is controlled through metabolite-sensing proteins. Low expression, interspecies differences, and the existence of multiple EEC subtypes have posed challenges to the study of these sensors. We describe differentiation of stomach EECs to complement existing intestinal organoid protocols. CD200 emerged as a pan-EEC surface marker, allowing deep transcriptomic profiling from primary human tissue along the stomach-intestinal tract. We generated loss-of-function mutations in 22 receptors and subjected organoids to ligand-induced secretion experiments. We delineate the role of individual human EEC sensors in the secretion of hormones, including GLP-1. These represent potential pharmacological targets to influence appetite, bowel movement, insulin sensitivity, and mucosal immunity.

Indexed as

Enteroendocrine CellsGlucagon-Like Peptide 1OrganoidsCell DifferentiationGastric Inhibitory PolypeptideGastric MucosaGene Expression ProfilingHumansTranscriptomeGastric Inhibitory PolypeptideGlucagon-Like Peptide 1

Identifiers

PMID39418382
PMCPMC7616728

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.